«SGLT2 INHIBITORS: RATIONALE FOR THE USE IN HEART FAILURE», RESOLUTION ON THE RESULTS OF THE PANEL OF EXPERTS WITH INTERNATIONAL PARTICIPATION, ALMATY

Abstract

1Al-Farabi Kazakh National University, Almaty, Kazakhstan 2 Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan 3 FSBI National Medical Research Center for Cardiology of the Ministry of Health of Russia, Moscow, Russia 4 Astana Medical University, Astana, Kazakhstan 5 Kazakh-Russian Medical University, Almaty, Kazakhstan 6Almazov National Medical Research Centre, Petersburg, Russia 7 First St. Petersburg state medical university. acad. I.P. Pavlova, St. Petersburg, Russia *e-mail: abzaliyeva.symbat@gmail.com